Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medistim Director's Dealing 2023

May 2, 2023

3662_dirs_2023-05-02_69efb22c-4e4a-4fd4-8239-7e616b1da8d5.html

Director's Dealing

Open in viewer

Opens in your device viewer

Notification of trade

Notification of trade

President and CEO in Medistim ASA, Kari E. Krogstad, has sold 37,719 shares to Medistim’s largest shareholder Aeternum Capital AS, at 265.00 NOK per share. The sale is related to the CEO’s private economy and need to free up liquidity. After the sale, Kari E. Krogstad holds a total of 38,083 shares in Medistim and Aeternum Capital AS holds 1,900,219 Medistim shares, which represent 10.16 % of the total shares in Medistim.